prnewswire.com
Negativewww.prnewswire.com ·
resurge therapeutics announces positive clinical results from two studies of its intraprostatic drug elution platform for benign prostatic hyperplasia bph at aua 2026 302771281
CRISISLEX_T11_UPDATESSYMPATHYPROTESTEPU_POLICY_REGULATORYTAX_DISEASE_HYPERPLASIA

Topic context
This topic has been covered 348218 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
